Alnylam Pharmaceuticals
Manager, Research & Development Communications
Alnylam Pharmaceuticals, Cambridge, Massachusetts, us, 02140
This role is considered Hybrid.OverviewThe Manager of R&D Communications is a science writer who crafts short- and long-form content to advance Alnylam's reputation as
the
leader in RNAi interference therapeutics. This role will be responsible for shaping social media posts, profiles, feature stories, video scripts, PowerPoint presentations, fact sheets, Q&As, and other materials that convey the power and promise of our innovative platform and pipeline for a variety of audiences, including scientists and the science-curious public. The successful candidate will be a storyteller at heart who is able to understand and translate complex science into clear and concise copy that engages key audiences. As part of the Investor Relations & Corporate Communications team, reporting to the Director of R&D Communications, this role will collaborate closely with the team as well as with scientists in a fast-paced environment to conceptualize and bring to life content that educates, entertains and inspires audiences.Key ResponsibilitiesDevelop short- and long-form content that delivers key messages about Alnylam's therapeutic platform and pipeline while entertaining and inspiring audiences.Collaborate with company researchers-including senior leaders in R&D-to translate science for a variety of audiences, including the science-curious public.Collaborate with internal corporate branding and creative teams and agency partners to iteratively shape content, including multimedia; embrace a "test and learn" mindset to optimize materials for target audiences.Propose and produce content series to advance Alnylam's reputation as
the
leader in RNAi therapeutics.Draft Q&As and other materials in support of pipeline milestone communications.QualificationsBachelor's degree in related field required.Minimum of 5 years of experience required, preferably in a journalism or communications role.Exceptional writing and editing skills (clips are required); strong oral communications skills and ability to convey complex science for a variety of audiences.Experience collaboratively shaping multimedia content such as videos and podcasts.Ability to deliver products that engage, excite, and motivate audiences.Ability to work independently and use sound judgment in decision-making, including setting and managing priorities and meeting competing deadlines.Demonstrated ability to maintain confidentiality.Comfortable with accepting feedback and adapting to deliver the desired product.Meticulous attention to detail and commitment to high quality and timely work product.About Alnylam:
Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by "interfering" with mRNA that cause or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality.Our culture:
Our people-first culture is guided by our core values: fiercely innovative, open culture, purposeful urgency, passion for excellence, and commitment to people, and these values influence how we work and the business decisions we make. Thanks to feedback from our employees over the years, we've been fortunate to be named a top employer around the world. Alnylam is extremely proud to have been recognized as the #1 Large Employer by Boston Globe Top Places to Work in 2023 for the third consecutive year, one of Science Magazine's Top Biopharma Employers, one of America's Most Responsible Companies for 2024 by Newsweek, a Fast Company Best Workplace for Innovators, and a Great Place to Work in Canada, France, Italy, Spain, Switzerland, and UK - among others.At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. We are dedicated to building an environment where employees can feel that they belong, can bring their authentic selves to work, and achieve to their full potential. By empowering employees to embrace their unique differences at work, our business grows stronger with advanced and original thinking, allowing us to bring groundbreaking medicines to patients. Qualified applicants will receive consideration for employment without regard to their race, color, religion, age, sex, sexual orientation, gender identity or expression, national origin, ethnicity, marital status, protected veteran status, disability, or any other characteristics prohibited by law.
#J-18808-Ljbffr
the
leader in RNAi interference therapeutics. This role will be responsible for shaping social media posts, profiles, feature stories, video scripts, PowerPoint presentations, fact sheets, Q&As, and other materials that convey the power and promise of our innovative platform and pipeline for a variety of audiences, including scientists and the science-curious public. The successful candidate will be a storyteller at heart who is able to understand and translate complex science into clear and concise copy that engages key audiences. As part of the Investor Relations & Corporate Communications team, reporting to the Director of R&D Communications, this role will collaborate closely with the team as well as with scientists in a fast-paced environment to conceptualize and bring to life content that educates, entertains and inspires audiences.Key ResponsibilitiesDevelop short- and long-form content that delivers key messages about Alnylam's therapeutic platform and pipeline while entertaining and inspiring audiences.Collaborate with company researchers-including senior leaders in R&D-to translate science for a variety of audiences, including the science-curious public.Collaborate with internal corporate branding and creative teams and agency partners to iteratively shape content, including multimedia; embrace a "test and learn" mindset to optimize materials for target audiences.Propose and produce content series to advance Alnylam's reputation as
the
leader in RNAi therapeutics.Draft Q&As and other materials in support of pipeline milestone communications.QualificationsBachelor's degree in related field required.Minimum of 5 years of experience required, preferably in a journalism or communications role.Exceptional writing and editing skills (clips are required); strong oral communications skills and ability to convey complex science for a variety of audiences.Experience collaboratively shaping multimedia content such as videos and podcasts.Ability to deliver products that engage, excite, and motivate audiences.Ability to work independently and use sound judgment in decision-making, including setting and managing priorities and meeting competing deadlines.Demonstrated ability to maintain confidentiality.Comfortable with accepting feedback and adapting to deliver the desired product.Meticulous attention to detail and commitment to high quality and timely work product.About Alnylam:
Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by "interfering" with mRNA that cause or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality.Our culture:
Our people-first culture is guided by our core values: fiercely innovative, open culture, purposeful urgency, passion for excellence, and commitment to people, and these values influence how we work and the business decisions we make. Thanks to feedback from our employees over the years, we've been fortunate to be named a top employer around the world. Alnylam is extremely proud to have been recognized as the #1 Large Employer by Boston Globe Top Places to Work in 2023 for the third consecutive year, one of Science Magazine's Top Biopharma Employers, one of America's Most Responsible Companies for 2024 by Newsweek, a Fast Company Best Workplace for Innovators, and a Great Place to Work in Canada, France, Italy, Spain, Switzerland, and UK - among others.At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. We are dedicated to building an environment where employees can feel that they belong, can bring their authentic selves to work, and achieve to their full potential. By empowering employees to embrace their unique differences at work, our business grows stronger with advanced and original thinking, allowing us to bring groundbreaking medicines to patients. Qualified applicants will receive consideration for employment without regard to their race, color, religion, age, sex, sexual orientation, gender identity or expression, national origin, ethnicity, marital status, protected veteran status, disability, or any other characteristics prohibited by law.
#J-18808-Ljbffr